pimagedine has been researched along with Encephalopathy, Traumatic in 1 studies
pimagedine: diamine oxidase & nitric oxide synthase inhibitor; an advanced glycosylation end product inhibitor; used in the treatment of diabetic complications; structure
aminoguanidine : A one-carbon compound whose unique structure renders it capable of acting as a derivative of hydrazine, guanidine or formamide.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, W | 1 |
| Shen, M | 1 |
| Sun, K | 1 |
| Wang, Y | 1 |
| Wang, X | 1 |
| Jin, X | 1 |
| Xu, J | 1 |
| Ding, L | 1 |
| Sun, X | 1 |
1 other study available for pimagedine and Encephalopathy, Traumatic
| Article | Year |
|---|---|
Aminoguanidine reverses cognitive deficits and activation of cAMP/CREB/BDNF pathway in mouse hippocampus after traumatic brain injury (TBI).
Topics: Animals; Brain Injuries, Traumatic; Brain-Derived Neurotrophic Factor; Cognition Disorders; CREB-Bin | 2018 |